| Primary |
| Thrombocytopenia |
39.8% |
| Idiopathic Thrombocytopenic Purpura |
21.4% |
| Hepatitis C |
8.2% |
| Hypertension |
6.7% |
| Supplementation Therapy |
3.4% |
| Prophylaxis |
2.4% |
| Myelodysplastic Syndrome |
2.1% |
| Acute Myeloid Leukaemia |
2.0% |
| Anxiety |
1.6% |
| Diabetes Mellitus |
1.6% |
| Depression |
1.3% |
| Immune Thrombocytopenic Purpura |
1.3% |
| Aplastic Anaemia |
1.1% |
| Dyspepsia |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Anaemia |
1.0% |
| Contraception |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Portal Hypertension |
1.0% |
| Autoimmune Thrombocytopenia |
0.8% |
|
| Pyrexia |
10.6% |
| Chest Pain |
8.8% |
| Vomiting |
8.1% |
| Cataract |
6.9% |
| Death |
6.9% |
| Visual Acuity Reduced |
6.9% |
| Portal Vein Thrombosis |
5.6% |
| Thrombocytopenia |
5.6% |
| Sepsis |
5.0% |
| Pleural Effusion |
4.4% |
| Renal Failure Acute |
4.4% |
| Asthenia |
3.8% |
| Oedema Peripheral |
3.8% |
| Retinal Haemorrhage |
3.8% |
| Musculoskeletal Chest Pain |
3.1% |
| Gait Disturbance |
2.5% |
| Haemolytic Anaemia |
2.5% |
| Jaundice |
2.5% |
| Myocardial Infarction |
2.5% |
| Pancytopenia |
2.5% |
|
| Secondary |
| Thrombocytopenia |
65.4% |
| Hepatitis C |
10.0% |
| Idiopathic Thrombocytopenic Purpura |
4.3% |
| Product Used For Unknown Indication |
4.1% |
| Supplementation Therapy |
2.6% |
| Foetal Exposure Timing Unspecified |
1.7% |
| Prophylaxis |
1.3% |
| Depression |
1.1% |
| Portal Hypertension |
1.1% |
| Acute Myeloid Leukaemia |
0.9% |
| Antiviral Prophylaxis |
0.9% |
| Asthma |
0.9% |
| Diabetes Mellitus |
0.9% |
| Myelodysplastic Syndrome |
0.9% |
| Abdominal Pain |
0.7% |
| Antifungal Prophylaxis |
0.7% |
| Hypertension |
0.7% |
| Hypothyroidism |
0.7% |
| Osteoporosis |
0.7% |
| Osteoporosis Prophylaxis |
0.7% |
|
| Cataract |
8.7% |
| Death |
8.7% |
| Pleural Effusion |
8.0% |
| Thrombocytopenia |
8.0% |
| Pancytopenia |
7.2% |
| Ascites |
6.5% |
| Pyrexia |
6.5% |
| Oedema Peripheral |
5.8% |
| Visual Acuity Reduced |
5.1% |
| Peritonitis Bacterial |
4.3% |
| Vomiting |
4.3% |
| Febrile Neutropenia |
3.6% |
| Non-cardiac Chest Pain |
3.6% |
| Hepatitis Alcoholic |
2.9% |
| Jaundice |
2.9% |
| Pericarditis |
2.9% |
| Pleurisy |
2.9% |
| Portal Vein Thrombosis |
2.9% |
| Retinal Haemorrhage |
2.9% |
| Hepatic Neoplasm Malignant |
2.2% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
43.4% |
| Product Used For Unknown Indication |
25.6% |
| Hepatitis C |
9.6% |
| Thrombocytopenia |
5.5% |
| Autoimmune Thrombocytopenia |
1.8% |
| Hypertension |
1.8% |
| Muscle Spasms |
1.8% |
| Immunisation |
1.4% |
| Supplementation Therapy |
1.4% |
| Systemic Lupus Erythematosus |
1.4% |
| Anaemia Of Malignant Disease |
0.9% |
| Immune Thrombocytopenic Purpura |
0.9% |
| Lymphoma |
0.9% |
| Osteoporosis |
0.9% |
| Anaemia |
0.5% |
| Anticoagulant Therapy |
0.5% |
| Chronic Lymphocytic Leukaemia |
0.5% |
| Deep Vein Thrombosis |
0.5% |
| Embolism Venous |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
|
| Drug Ineffective |
16.1% |
| Bone Marrow Reticulin Fibrosis |
12.5% |
| Therapeutic Response Decreased |
12.5% |
| Thrombocytopenia |
8.9% |
| Petechiae |
5.4% |
| Platelet Count Increased |
5.4% |
| Back Pain |
3.6% |
| Haemorrhage |
3.6% |
| Hospitalisation |
3.6% |
| Hypersensitivity |
3.6% |
| Hypoglycaemic Coma |
3.6% |
| Normochromic Normocytic Anaemia |
3.6% |
| Pulmonary Embolism |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Anaemia |
1.8% |
| Anaphylactic Reaction |
1.8% |
| Arthralgia |
1.8% |
| Benign Prostatic Hyperplasia |
1.8% |
| Death |
1.8% |
| Decreased Appetite |
1.8% |
|
